{"disease":{"id":"meningococcal-infection","name":"meningococcal infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04664569","title":"National Bacterial Meningitis Study","phase":"","overall_status":"RECRUITING","enrollment_count":8230,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT02842853","title":"Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3344,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03673462","title":"Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2797,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03537508","title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the US","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2627,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02199691","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1715,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03547271","title":"Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine When Co-administered With Routine Pediatric Vaccines in Healthy Infants and Toddlers in Europe","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1660,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT07135986","title":"Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1602,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03378258","title":"Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA.","phase":"","overall_status":"COMPLETED","enrollment_count":1329,"lead_sponsor_name":"Belfast Health and Social Care Trust","has_results":false},{"nct_id":"NCT02864927","title":"Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":1311,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT03077438","title":"Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1000,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03691610","title":"Immunogenicity and Safety Study of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":950,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02955797","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":918,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02842866","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":907,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02752906","title":"Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":810,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03632720","title":"Immunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine in Infants and Toddlers When Administered Concomitantly With Routine Pediatric Vaccines in the United Kingdom","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":788,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT01340898","title":"Immunogenicity and Safety Study of GSK Biologicals' Meningococcal Conjugate Vaccine When Co-administered With Routine Vaccines in Healthy Infants and Toddlers","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":753,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01682876","title":"Immunogenicity, Safety and 1 Year Persistence of Antibodies After Either One or Two Doses of Meningococcal ACWY Conjugate Vaccine in Healthy Children 2 Through 10 Years of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":715,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01543087","title":"Duration of hSBA Response After a Primary Series of Bivalent rLP2086 Followed by a Booster Dose","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":698,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01049035","title":"A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":580,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03630705","title":"Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":525,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04142242","title":"Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":471,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT06228586","title":"Study on a MenACYW Conjugate Vaccine Administered as a Single Dose in Participants Aged 12 Months and Older in Vietnam","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":447,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT01732627","title":"Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":301,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT01890759","title":"Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03869866","title":"Study to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) in Older Adults in Turkey and Lebanon","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":290,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT00443846","title":"RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":247,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02173704","title":"Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":225,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02640404","title":"Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":224,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT03205358","title":"Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":188,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02287688","title":"Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study","phase":"","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02451514","title":"A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT05981599","title":"Epidemiological, Clinical and Biological Caracteristics of Patients Presenting With Invasive Meningococcal Disease","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT04236960","title":"Safety Evaluation of Meningococcal Group ACYW135 Conjugate Vaccine in 2-month to 55 Years Old Population.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":100,"lead_sponsor_name":"Walvax Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT03798574","title":"The Long-term Impact of Invasive Meningococcal Disease in Australian Adolescents and Young Adults","phase":"","overall_status":"COMPLETED","enrollment_count":98,"lead_sponsor_name":"University of Adelaide","has_results":false},{"nct_id":"NCT02223637","title":"Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry","phase":"","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT03476135","title":"Immunogenicity and Safety of a Booster Dose of a Quadrivalent Meningococcal Conjugate Vaccine in Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":91,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT02591290","title":"Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":true},{"nct_id":"NCT04843111","title":"Observational, Passive Surveillance Program to Collect Information on Women and Their Offspring Exposed to MenQuadfi® During Pregnancy, in United States (US)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Sanofi Pasteur, a Sanofi Company","has_results":false},{"nct_id":"NCT02041663","title":"Septic cArdiac Deficiency and MenIngococcal seveRe Sepsis","phase":"NA","overall_status":"COMPLETED","enrollment_count":35,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":39},"guidelines":[],"source":"Drug Landscape verified database"}